title: Reviewing the studies of the National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Network: outcomes and clinical findings.
authors.forename: Hee Soo
authors.initials: HS
authors.lastname: Jung
authors.forename: Lewis J
authors.initials: LJ
authors.lastname: Kaplan
authors.forename: Pauline K
authors.initials: PK
authors.lastname: Park
mesh_terms: D055371:Acute Lung Injury / Q000628:therapy; D000420:Albuterol / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D019587:Dietary Supplements; D004750:Enteral Nutrition / Q000379:methods; D005440:Fluid Therapy / Q000379:methods; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D010431:Pentoxifylline / Q000031:analogs & derivatives / Q000627:therapeutic use; D012121:Respiration, Artificial / Q000379:methods; D012128:Respiratory Distress Syndrome / Q000503:physiopathology / Q000628:therapy*; D013990:Tidal Volume / Q000502:physiology; D016896:Treatment Outcome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D001993:Bronchodilator Agents; D005938:Glucocorticoids; C025189:lisofylline; D000420:Albuterol; D010431:Pentoxifylline